Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study

Abstract Background The bacterium Yersinia enterocolitica causes gastroenteritis in humans. The study aimed to develop a diagnostic enzyme-linked immunosorbent assay (ELISA) for detection of Yersinia enterocolitica O:3 LPS antibodies in sera from Danish patients with suspected Yersinia enterocolitic...

Full description

Bibliographic Details
Main Authors: Tine Dalby, Eva Rasmussen, Peter Schiellerup, Karen Angeliki Krogfelt
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Microbiology
Subjects:
LPS
Online Access:http://link.springer.com/article/10.1186/s12866-017-1035-1
id doaj-e3db4fcbd36449b1b2093d54e7555687
record_format Article
spelling doaj-e3db4fcbd36449b1b2093d54e75556872020-11-24T22:15:52ZengBMCBMC Microbiology1471-21802017-05-011711710.1186/s12866-017-1035-1Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up studyTine Dalby0Eva Rasmussen1Peter Schiellerup2Karen Angeliki Krogfelt3Department of Bacteria, Parasites and Fungi, Statens Serum InstitutDepartment of Bacteria, Parasites and Fungi, Statens Serum InstitutDepartment of Bacteria, Parasites and Fungi, Statens Serum InstitutDepartment of Bacteria, Parasites and Fungi, Statens Serum InstitutAbstract Background The bacterium Yersinia enterocolitica causes gastroenteritis in humans. The study aimed to develop a diagnostic enzyme-linked immunosorbent assay (ELISA) for detection of Yersinia enterocolitica O:3 LPS antibodies in sera from Danish patients with suspected Yersinia enterocolitica O:3 gastrointestinal infection. As a part of this, antibody decay profiles after culture confirmed Yersinia enteritis were studied. Results An ELISA using Yersinia enterocolitica O:3 LPS as the coating antigen was developed for measuring IgA, IgG and IgM specific antibodies. A longitudinal collection of 220 sera drawn between 20 and 1053 days after onset of symptoms from 85 adult Danish patients with verified Yersinia enteritis were examined. A control group of 100 sera from healthy Danish blood-donors were analysed in order to determine the cut-off for interpretation of results. Serum samples from 62 out of 81 patients who delivered either the first or the second sample were found positive for specific antibodies against Yersinia enterocolitica O:3 LPS (77%). For samples collected within 60 days after onset of symptoms (n = 48) sensitivities of 58%, 42% and 79% for IgA, IgG and IgM antibodies were found. A sensitivity of 81% was found for these samples when using the definition of a positive result in either IgA, IgG or IgM as a combined positive. All samples received up to 36 days after onset of symptoms (n = 10) were found to be positive using this definition. For the period 61 to 90 days after onset of symptoms (n = 32), a combined sensitivity of 63% was found. The antibody levels as well as decay profiles for the three different immunoglobulin classes for the individual patients exhibited a large degree of variation. Conclusions Using a definition of positive as a positive result for either IgA, IgG or IgM antibodies, a diagnostic sensitivity of 81% was achieved for samples received within 60 days after onset of symptoms. In particular, the levels of specific IgM antibodies were elevated. In comparison, the standard tube-agglutination assay achieved a sensitivity of 60% on the same samples. The sensitivity of the ELISA decreased the longer the duration of time since onset of symptoms. The ELISA was highly specific for Yersinia when testing sera from individuals with confirmed gastrointestinal infections by other bacteria. Moreover, the knowledge gained from this longitudinal study of antibody decay profiles can be used in future epidemiological studies of seroprevalence.http://link.springer.com/article/10.1186/s12866-017-1035-1YersiniaEnzyme-linked immunosorbent assayLPSAntibodiesHumanImmunology
collection DOAJ
language English
format Article
sources DOAJ
author Tine Dalby
Eva Rasmussen
Peter Schiellerup
Karen Angeliki Krogfelt
spellingShingle Tine Dalby
Eva Rasmussen
Peter Schiellerup
Karen Angeliki Krogfelt
Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study
BMC Microbiology
Yersinia
Enzyme-linked immunosorbent assay
LPS
Antibodies
Human
Immunology
author_facet Tine Dalby
Eva Rasmussen
Peter Schiellerup
Karen Angeliki Krogfelt
author_sort Tine Dalby
title Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study
title_short Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study
title_full Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study
title_fullStr Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study
title_full_unstemmed Development of an LPS-based ELISA for diagnosis of Yersinia enterocolitica O:3 infections in Danish patients: a follow-up study
title_sort development of an lps-based elisa for diagnosis of yersinia enterocolitica o:3 infections in danish patients: a follow-up study
publisher BMC
series BMC Microbiology
issn 1471-2180
publishDate 2017-05-01
description Abstract Background The bacterium Yersinia enterocolitica causes gastroenteritis in humans. The study aimed to develop a diagnostic enzyme-linked immunosorbent assay (ELISA) for detection of Yersinia enterocolitica O:3 LPS antibodies in sera from Danish patients with suspected Yersinia enterocolitica O:3 gastrointestinal infection. As a part of this, antibody decay profiles after culture confirmed Yersinia enteritis were studied. Results An ELISA using Yersinia enterocolitica O:3 LPS as the coating antigen was developed for measuring IgA, IgG and IgM specific antibodies. A longitudinal collection of 220 sera drawn between 20 and 1053 days after onset of symptoms from 85 adult Danish patients with verified Yersinia enteritis were examined. A control group of 100 sera from healthy Danish blood-donors were analysed in order to determine the cut-off for interpretation of results. Serum samples from 62 out of 81 patients who delivered either the first or the second sample were found positive for specific antibodies against Yersinia enterocolitica O:3 LPS (77%). For samples collected within 60 days after onset of symptoms (n = 48) sensitivities of 58%, 42% and 79% for IgA, IgG and IgM antibodies were found. A sensitivity of 81% was found for these samples when using the definition of a positive result in either IgA, IgG or IgM as a combined positive. All samples received up to 36 days after onset of symptoms (n = 10) were found to be positive using this definition. For the period 61 to 90 days after onset of symptoms (n = 32), a combined sensitivity of 63% was found. The antibody levels as well as decay profiles for the three different immunoglobulin classes for the individual patients exhibited a large degree of variation. Conclusions Using a definition of positive as a positive result for either IgA, IgG or IgM antibodies, a diagnostic sensitivity of 81% was achieved for samples received within 60 days after onset of symptoms. In particular, the levels of specific IgM antibodies were elevated. In comparison, the standard tube-agglutination assay achieved a sensitivity of 60% on the same samples. The sensitivity of the ELISA decreased the longer the duration of time since onset of symptoms. The ELISA was highly specific for Yersinia when testing sera from individuals with confirmed gastrointestinal infections by other bacteria. Moreover, the knowledge gained from this longitudinal study of antibody decay profiles can be used in future epidemiological studies of seroprevalence.
topic Yersinia
Enzyme-linked immunosorbent assay
LPS
Antibodies
Human
Immunology
url http://link.springer.com/article/10.1186/s12866-017-1035-1
work_keys_str_mv AT tinedalby developmentofanlpsbasedelisafordiagnosisofyersiniaenterocoliticao3infectionsindanishpatientsafollowupstudy
AT evarasmussen developmentofanlpsbasedelisafordiagnosisofyersiniaenterocoliticao3infectionsindanishpatientsafollowupstudy
AT peterschiellerup developmentofanlpsbasedelisafordiagnosisofyersiniaenterocoliticao3infectionsindanishpatientsafollowupstudy
AT karenangelikikrogfelt developmentofanlpsbasedelisafordiagnosisofyersiniaenterocoliticao3infectionsindanishpatientsafollowupstudy
_version_ 1725792545583136768